Matthias Schroff

Matthias Schroff, PhD, is Inceptor Bio’s Chief Executive Officer. Dr. Schroff has extensive biopharmaceutical leadership experience with a track record of success building companies and developing new medicines in immuno-oncology, inflammatory diseases, and genetic disorders. Dr. Schroff was most recently Chief Executive Officer of Exicure, a publicly traded biotechnology company developing gene regulatory and immunotherapeutic drugs. Dr. Schroff earned a degree in Biochemistry at the University of Leibniz University Hannover and his Doctorate of Molecular Biology from Freie University Berlin.